114 related articles for article (PubMed ID: 8104074)
1. Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.
Manna M; Nesci S; Andreani M; Tonucci P; Lucarelli G
Bone Marrow Transplant; 1993; 12 Suppl 1():70-3. PubMed ID: 8104074
[No Abstract] [Full Text] [Related]
2. Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Tang-naitrisorana Y; Issaragrisil S; Visuthisakchai S; Suvatte V; Piankijakum A
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():291-5. PubMed ID: 8629127
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in thalassemia. The Cagliari team experience.
Contu L; La Nasa G; Pizzati A; Arras M; Vacca A; Ledda A; Carcassi C; Orrù S; Mulargia M; Boero R
Bone Marrow Transplant; 1993; 12 Suppl 1():45-6. PubMed ID: 8374560
[No Abstract] [Full Text] [Related]
4. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for children with thalassemia: two years' experience with low-dose busulfan, citoxan and GM-CSF.
Miniero R; Vassallo E; Busca A; Piga A; Perugini L; Madon E
Bone Marrow Transplant; 1993; 12 Suppl 1():51-3. PubMed ID: 8374564
[No Abstract] [Full Text] [Related]
6. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
[TBL] [Abstract][Full Text] [Related]
7. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
[TBL] [Abstract][Full Text] [Related]
8. Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation.
Roberts C; Kean L; Archer D; Balkan C; Hsu LL
Ann N Y Acad Sci; 2005; 1054():423-8. PubMed ID: 16339691
[TBL] [Abstract][Full Text] [Related]
9. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation.
Andreani M; Nesci S; Lucarelli G; Tonucci P; Rapa S; Angelucci E; Persini B; Agostinelli F; Donati M; Manna M
Bone Marrow Transplant; 2000 Feb; 25(4):401-4. PubMed ID: 10723583
[TBL] [Abstract][Full Text] [Related]
12. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
13. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
[TBL] [Abstract][Full Text] [Related]
14. Mixed chimerism in thalassemic patients after bone marrow transplantation.
Nesci S; Manna M; Andreani M; Fattorini P; Graziosi G; Lucarelli G
Bone Marrow Transplant; 1992 Aug; 10(2):143-6. PubMed ID: 1525603
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic beta-cell function before and after bone marrow transplantation for thalassemia.
Galimberti M; De Sanctis V; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Giardini C; Erer B; Gaziev J; Balducci R
Bone Marrow Transplant; 1993; 12 Suppl 1():102-3. PubMed ID: 8374544
[No Abstract] [Full Text] [Related]
16. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.
Chandy M; Balasubramanian P; Ramachandran SV; Mathews V; George B; Dennison D; Krishnamoorthy R; Srivastava A
Bone Marrow Transplant; 2005 Nov; 36(10):839-45. PubMed ID: 16151422
[TBL] [Abstract][Full Text] [Related]
19. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia.
Andreani M; Manna M; Lucarelli G; Tonucci P; Agostinelli F; Ripalti M; Rapa S; Talevi N; Galimberti M; Nesci S
Blood; 1996 Apr; 87(8):3494-9. PubMed ID: 8605369
[TBL] [Abstract][Full Text] [Related]
20. Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
Erer B; Angelucci E; Baronciani D; Tomasucci M; Giardini C; Gaziev J
Bone Marrow Transplant; 1993; 12 Suppl 1():93-5. PubMed ID: 8374576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
